The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
We know that cash is expected to be sufficient to fund Avacta into 2023. Sorry Ray but the likelyhood of a placing in the foreseeable future is near zero in my estimation, particularly since LFT sales will inevitably begin to ramp up from here.
Just a word on BAMS, HMG spiked that one, what with MPs apparantly wanting to get their noses deep into the PCR trough, the delay with BAMS testing appeared calculated to allow PCR testing to be established as the gold-standard, whatever the merits of BAMS. I hope this will figure in the Covid investigation. But BAMS is not dead, its earning and likely to de taken forward by Adeptrix and Bruker for various targets.
Regarding the AVA600 process, to my mind this will be very leaky, doctors, patients, relatives will all have an inkling way before year end. To my mind this suggests an RNS at an early stage along the lines of "progressing well with no contraindications".
One thing to keep in mind is that AVA6000 is not a new drug it is a pro-drug of Doxorubicin. The toxicity of Dox is well known so I suspect there will be ramping from the standard dose pretty much from the outset and pretty quickly it will become evident whether the concept works because folk wont feel horribly ill, as they normally do, after their treatment. Lets hope its a huge success for everyones sake but first and foremost for the cancer patients because if it works as predicted it marks a new era in cancer treatment.
An important point here is that PHE has confirmed in preliminary investigation that as we suspected vaccinated individuals carry the same amount of virus as the unvaccinated and can pass on tne virus. This of course rubbishes the idea of a vaccination passport entirely. There is only testing.
Just a personal observation on case numbers. Throughout the pandemic I had few friends and acquaintances who contracted Covid. Now suddenly I have three. I have become very suspicious of the Government as a consequence of its actions throughout the pandemic and obscuring actual case numbers, given that most vaccinated folk do not end up in hospital, either through incompetence or design does not seem out of bounds. Never thought I would actually say that.
Quite right Energy. The least that can be said on the LFT front is that Avacta has developed a world beating product using Affimers and big pharma knows it. AffiDX is established and will address a range of targets going forward so Avacta has grown a diagnostics business essentially overnight and of course the AffiDX SARS-CoV-2 Antigen LFT will sell in numbers and every one sold is more cash in the bank. Patience needed is all.
MDx you are seemingly well wide of the mark with respect to the ct infectivity boundary threshold which is acknowledged to be around ct 27 accepting that correlation of infectivity and ct value is an approximation. Comment?
I think we are going to have to wait for a) home use b) first seriously large order, to get the jumps into the blue we all want. The good news is that both are within shouting distance I suspect. Could be however, that b) is pedicated on a).
My conclusion, for what it's worth, is that alot is hanging on Medusa19 achieving self test for AffiDx. When that drops my feeling is there will be a cascade of communications. But it has been a loooong wait. GLA.
The 60% figure confirms to me we are governed by cretins or folk on the receiving end of brown envelopes. So entry to an event is by LFT result, I opt for an Avacta LFT at 100% sensitivity across the infectious range whereas you opt for a 60% LFT. We both have negative results but you have Covid and end up sitting next to me. Thanks Boris. Why not drop it to 50% and sort it with a coin toss is my suggestion to the Prime Moron.
I feel everyone needs to lighten up on perceived deadlines. The programme dates Avacta provides are as Al has explained necessarily indicative because many factors are beyond Avactas direct control. This is just a fact of life. Some will choose to exploit 'missed deadlines' for their own advantage, fact is all dates are indicative and the alternative would be to have no information at all. So my advice is not to get too excited about deadlines. As I say to my kids if you can't influence an outcome its pointless expending energy worrying about it.